170 related articles for article (PubMed ID: 2821115)
1. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
[TBL] [Abstract][Full Text] [Related]
2. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
3. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
4. Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates.
Zarling JM; Moran PA; Grosmaire LS; McClure J; Shriver K; Ledbetter JA
J Immunol; 1988 Apr; 140(8):2609-13. PubMed ID: 2965725
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
7. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
[TBL] [Abstract][Full Text] [Related]
9. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
[TBL] [Abstract][Full Text] [Related]
10. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
Perrin LH; Tishon A; Oldstone MB
J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
[TBL] [Abstract][Full Text] [Related]
11. Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.
Ljunggren K; Chiodi F; Biberfeld G; Norrby E; Jondal M; Fenyö EM
J Immunol; 1988 Jan; 140(2):602-5. PubMed ID: 3335784
[TBL] [Abstract][Full Text] [Related]
12. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
[TBL] [Abstract][Full Text] [Related]
13. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
[TBL] [Abstract][Full Text] [Related]
14. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
[TBL] [Abstract][Full Text] [Related]
15. [Immunization against the human immunodeficiency virus in Zaire].
Zagury D; Salaün JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z
Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
Jenkins M; Mills J; Kohl S
Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
[TBL] [Abstract][Full Text] [Related]
17. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.
Sinclair AL; Habeshaw JA; Muir L; Chandler P; Forster S; Cruickshank K; Dalgleish AG
AIDS; 1988 Dec; 2(6):465-72. PubMed ID: 3149493
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.
Orlikowsky TW; Wang ZQ; Dudhane A; Dannecker GE; Niethammer D; Wormser GP; Hoffmann MK; Horowitz HW
J Infect Dis; 2001 Nov; 184(10):1328-30. PubMed ID: 11679924
[TBL] [Abstract][Full Text] [Related]
20. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
